Clinical Trial: Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(L), US-Humalog(R), and EU-Humalog(R)

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07165652) titled 'Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(L), US-Humalog(R), and EU-Humalog(R)' on Sept. 03.

Brief Summary: Study to demonstrate pharmacokinetic and pharmacodynamic similarity between NKF-INS(L), US-Humalog(R), and EU-Humalog(R)

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Healthy Male Adult Volunteers

Intervention: DRUG: NKF-INS(L)

Participants will receive a single subcutaneous dose of 0.3 IU/kg in either Treatment Period 1, Treatment Period 2, or Treatment period 3.

DRUG: US-Humalog(R)

Participants will receive a single subcutaneous dose of 0.3 IU/kg in ei...